WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO1994026107) PSYCHOSIS PROTECTING NUCLEIC ACID, PEPTIDES, COMPOSITIONS AND METHOD OF USE
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/1994/026107    International Application No.:    PCT/US1994/005445
Publication Date: 24.11.1994 International Filing Date: 13.05.1994
Chapter 2 Demand Filed:    06.12.1994    
IPC:
A61K 38/00 (2006.01), C07K 14/47 (2006.01), C07K 16/18 (2006.01)
Applicants: NEW YORK UNIVERSITY [US/US]; 550 First Avenue, Room MSB-153, New York, NY 10016 (US) (For All Designated States Except US).
FRIEDHOFF, Arnold, J. [US/US]; (US) (For US Only).
BASHAM, Daryl, A. [US/US]; (US) (For US Only).
MILLER, Jeanette, C. [US/US]; (US) (For US Only)
Inventors: FRIEDHOFF, Arnold, J.; (US).
BASHAM, Daryl, A.; (US).
MILLER, Jeanette, C.; (US)
Agent: LATKER, Norman, J.; Browdy and Neimark, 419 Seventh Street, N.W., Suite 300, Washington, DC 20004 (US)
Priority Data:
08/060,560 13.05.1993 US
Title (EN) PSYCHOSIS PROTECTING NUCLEIC ACID, PEPTIDES, COMPOSITIONS AND METHOD OF USE
(FR) ACIDE NUCLEIQUE, PEPTIDES, COMPOSITIONS ANTIPSYCHOTIQUES ET LEUR MODE D'UTILISATION
Abstract: front page image
(EN)Psychosis protecting (PP) nucleic acids and encoded PP peptides and related proteins, and antibodies, anti-idiotype antibodies, and fragments thereto, for treatment, diagnosis and/or research related to the protection from psychosis such as schizophrenia or related disorders, or symptoms thereof, and expression products, compositions and methods therefor, including treatment of schizophrenia and related disorders, as well as transgenic non-human mammals expressing PP peptide or related protein encoding nucleic acids.
(FR)L'invention concerne des acides nucléiques, des peptides PP (protection contre la psychose) et les protéines associées codés, des anticorps, des anticorps anti-idiotypes antipsychotiques et des fragments de ces derniers pour le traitement, le diagnostic et/ou la recherche relatifs à la protection contre la psychose telle que la schizophrénie ou des troubles associés, ou des symptômes de cette dernière. L'invention concerne également des produits d'expression, des compositions et des procédés à cet effet dont le traitement de la schizophrénie et de troubles associés, ainsi qu'un peptide PP d'expression transgénique non humain ou des acides nucléiques codant les protéines associées.
Designated States: AU, CA, JP, US.
European Patent Office (AT, BE, CH, DE, DK, ES, FR, GB, GR, IE, IT, LU, MC, NL, PT, SE).
Publication Language: English (EN)
Filing Language: English (EN)